_id
690f2f7bccc777a4e85d1630
Ticker
ASFX
Name
American Scientf
Exchange
OTCCE
Address
1112 Weston Road, Weston, FL, United States, 33326
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
-
Description
American Scientific Resources, Incorporated develops, manufactures, assembles, markets, and distributes medical products and devices for children and adults. It offers Thermofocus 5-in-1, a non-contact clinical thermometer; VeraTemp and VeraTemp+ non-contact thermometers; Scald Safe Water temperature disc, a warning disc that helps to ensure that a baby's bath water is at an appropriate temperature; and WhistleWatch, a flow monitoring device that allows parents to monitor their child's respiratory problems. The company also provides Kidz-Med portable ultrasonic nebulizer, which is used to treat asthma, bronchitis, allergies, and sinusitis; Kidz-Med Medicine Dispenser that consists of an orthodontic nipple attached to a medication chamber; and Kidz-Med Mommy Recorder, a voice-recording device, which allows a mother to record a message designed to calm baby when he or she is upset. In addition, it offers Bip DVDs, a video series to help children understand life events; Mebby product line that includes breast pumps, bisphenol A free baby bottles, digital scales, humidifiers, pacifiers, & sterilizers; and Wee Target, a toilet training device for young boys. Further, the company provides Disintegrator, a home needle and lancet destruction device, which enables patients who give themselves injections, including those suffering from multiple sclerosis or diabetes to properly and safely dispose of needles at home. American Scientific Resources distributes its products primarily through retail drug and grocery chains, and medical suppliers, as well as through its Web site and other on-line sites. The company is based in Weston, Florida. On February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against American Scientific Resources, Incorporated in the US Bankruptcy Court for the Southern District of Florida. On March 28, 2012, the involuntary petition was approved by the Court. American Scientific Resources, Inc. is in liquidation.
Last Close
0.0001
Volume
70
Current Price
-
Change
0
Last Updated
2026-01-20T15:44:49.113Z
Image
-
Ipo Date
-
Market Cap
1203
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2011-09-30
Revenue
439644
Cost Of Revenue
333559
Gross Profit
106085
Operating Expenses
1002800
Operating Income
-563156
Interest Expense
479708
Pretax Income
-784908
Net Income
-784908
Eps
-
Dividends Per Share
0
Shares Outstanding
30088761
Income Tax Expense
0
EBITDA
-
Operating Margin
-128.09363939915022
Total Other Income Expense Net
-221752
Cash
19618
Short Term Investments
0
Receivables
158024
Inventories
290000
Total Current Assets
635365
Property Plant Equipment
28648
Total Assets
1261164
Payables
1069109
Short Term Debt
285913
Long Term Debt
1551285
Total Liabilities
9215634
Equity
-7954475
Bs_currency_symbol
USD
Depreciation
16287
Change In Working Capital
-
Cash From Operations
-89896
Capital Expenditures
0
Cash From Investing
0
Cash From Financing
55000
Net Change In Cash
-34896
Cf_currency_symbol
USD
PE
-
PB
-
ROE
9.867502255019973
ROA
-62.236790774237136
FCF
-89896
Fcf Percent
-0.2044745293919626
Piotroski FScore
1
Health Score
33
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2011-09-30
Quarters > 0 > income Statement > revenue
439644
Quarters > 0 > income Statement > cost Of Revenue
333559
Quarters > 0 > income Statement > gross Profit
106085
Quarters > 0 > income Statement > operating Expenses
1002800
Quarters > 0 > income Statement > operating Income
-563156
Quarters > 0 > income Statement > interest Expense
479708
Quarters > 0 > income Statement > pretax Income
-784908
Quarters > 0 > income Statement > net Income
-784908
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-128.09363939915022
Quarters > 0 > income Statement > total Other Income Expense Net
-221752
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
19618
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
158024
Quarters > 0 > balance Sheet > inventories
290000
Quarters > 0 > balance Sheet > total Current Assets
635365
Quarters > 0 > balance Sheet > property Plant Equipment
28648
Quarters > 0 > balance Sheet > total Assets
1261164
Quarters > 0 > balance Sheet > payables
1069109
Quarters > 0 > balance Sheet > short Term Debt
285913
Quarters > 0 > balance Sheet > long Term Debt
1551285
Quarters > 0 > balance Sheet > total Liabilities
9215634
Quarters > 0 > balance Sheet > equity
-7954475
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-784908
Quarters > 0 > cash Flow > depreciation
16287
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-89896
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
0
Quarters > 0 > cash Flow > cash From Financing
55000
Quarters > 0 > cash Flow > net Change In Cash
-34896
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
9.867502255019973
Quarters > 0 > ratios > ROA
-62.236790774237136
Quarters > 0 > ratios > FCF
-89896
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.2044745293919626
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2011-06-30
Quarters > 1 > income Statement > revenue
222129
Quarters > 1 > income Statement > cost Of Revenue
142573
Quarters > 1 > income Statement > gross Profit
79556
Quarters > 1 > income Statement > operating Expenses
2741036
Quarters > 1 > income Statement > operating Income
-2518907
Quarters > 1 > income Statement > interest Expense
551778
Quarters > 1 > income Statement > pretax Income
-4009697
Quarters > 1 > income Statement > net Income
-4009697
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-1133.9838562276875
Quarters > 1 > income Statement > total Other Income Expense Net
-1490790
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
54514
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
51725
Quarters > 1 > balance Sheet > inventories
268328
Quarters > 1 > balance Sheet > total Current Assets
745128
Quarters > 1 > balance Sheet > property Plant Equipment
30939
Quarters > 1 > balance Sheet > total Assets
1387214
Quarters > 1 > balance Sheet > payables
862265
Quarters > 1 > balance Sheet > short Term Debt
268066
Quarters > 1 > balance Sheet > long Term Debt
45205
Quarters > 1 > balance Sheet > total Liabilities
9288700
Quarters > 1 > balance Sheet > equity
-7901491
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4009697
Quarters > 1 > cash Flow > depreciation
15479
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-816943
Quarters > 1 > cash Flow > capital Expenditures
16040
Quarters > 1 > cash Flow > cash From Investing
-16040
Quarters > 1 > cash Flow > cash From Financing
885022
Quarters > 1 > cash Flow > net Change In Cash
52039
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
50.74608070805877
Quarters > 1 > ratios > ROA
-289.04675125827737
Quarters > 1 > ratios > FCF
-832983
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.7499966235835935
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2011-03-31
Quarters > 2 > income Statement > revenue
101247
Quarters > 2 > income Statement > cost Of Revenue
92624
Quarters > 2 > income Statement > gross Profit
8623
Quarters > 2 > income Statement > operating Expenses
663738
Quarters > 2 > income Statement > operating Income
-562491
Quarters > 2 > income Statement > interest Expense
683564
Quarters > 2 > income Statement > pretax Income
-2133047
Quarters > 2 > income Statement > net Income
-2133047
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-555.5631277963791
Quarters > 2 > income Statement > total Other Income Expense Net
-1570556
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2475
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
17356
Quarters > 2 > balance Sheet > inventories
277571
Quarters > 2 > balance Sheet > total Current Assets
379480
Quarters > 2 > balance Sheet > property Plant Equipment
16383
Quarters > 2 > balance Sheet > total Assets
1021005
Quarters > 2 > balance Sheet > payables
1013536
Quarters > 2 > balance Sheet > short Term Debt
119694
Quarters > 2 > balance Sheet > long Term Debt
99075
Quarters > 2 > balance Sheet > total Liabilities
7623101
Quarters > 2 > balance Sheet > equity
-6602101
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2133047
Quarters > 2 > cash Flow > depreciation
15269
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-108449
Quarters > 2 > cash Flow > capital Expenditures
16040
Quarters > 2 > cash Flow > cash From Investing
-16040
Quarters > 2 > cash Flow > cash From Financing
95000
Quarters > 2 > cash Flow > net Change In Cash
-13449
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
32.30860903218536
Quarters > 2 > ratios > ROA
-208.91641079132816
Quarters > 2 > ratios > FCF
-124489
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.2295574189852538
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2010-12-31
Quarters > 3 > income Statement > revenue
283408
Quarters > 3 > income Statement > cost Of Revenue
252616
Quarters > 3 > income Statement > gross Profit
30792
Quarters > 3 > income Statement > operating Expenses
1069431
Quarters > 3 > income Statement > operating Income
-786023
Quarters > 3 > income Statement > interest Expense
397846
Quarters > 3 > income Statement > pretax Income
-2253130
Quarters > 3 > income Statement > net Income
-2253130
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-277.3467933156439
Quarters > 3 > income Statement > total Other Income Expense Net
-1467107
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
15924
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
81500
Quarters > 3 > balance Sheet > inventories
201010
Quarters > 3 > balance Sheet > total Current Assets
411318
Quarters > 3 > balance Sheet > property Plant Equipment
17656
Quarters > 3 > balance Sheet > total Assets
1068112
Quarters > 3 > balance Sheet > payables
1015119
Quarters > 3 > balance Sheet > short Term Debt
3008148.98
Quarters > 3 > balance Sheet > long Term Debt
227372
Quarters > 3 > balance Sheet > total Liabilities
6797276
Quarters > 3 > balance Sheet > equity
-5729164
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2253130
Quarters > 3 > cash Flow > depreciation
53968
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-242609
Quarters > 3 > cash Flow > capital Expenditures
4282
Quarters > 3 > cash Flow > cash From Investing
-4282
Quarters > 3 > cash Flow > cash From Financing
261870
Quarters > 3 > cash Flow > net Change In Cash
14979
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
39.32737830510699
Quarters > 3 > ratios > ROA
-210.94510688017735
Quarters > 3 > ratios > FCF
-246891
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.8711504262406142
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2010-12-31
Annuals > 0 > income Statement > revenue
862369
Annuals > 0 > income Statement > cost Of Revenue
754902
Annuals > 0 > income Statement > gross Profit
107467
Annuals > 0 > income Statement > operating Expenses
4049832
Annuals > 0 > income Statement > operating Income
-3187463
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-7040767
Annuals > 0 > income Statement > net Income
-7040767
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-369.6170664761836
Annuals > 0 > income Statement > total Other Income Expense Net
-3853304
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
15924
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
81500
Annuals > 0 > balance Sheet > inventories
201010
Annuals > 0 > balance Sheet > total Current Assets
411318
Annuals > 0 > balance Sheet > property Plant Equipment
17656
Annuals > 0 > balance Sheet > total Assets
1068112
Annuals > 0 > balance Sheet > payables
1015119
Annuals > 0 > balance Sheet > short Term Debt
3008148.98
Annuals > 0 > balance Sheet > long Term Debt
227372
Annuals > 0 > balance Sheet > total Liabilities
6797276
Annuals > 0 > balance Sheet > equity
-5729164
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7040767
Annuals > 0 > cash Flow > depreciation
214051
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-896346
Annuals > 0 > cash Flow > capital Expenditures
16414
Annuals > 0 > cash Flow > cash From Investing
-16414
Annuals > 0 > cash Flow > cash From Financing
917327
Annuals > 0 > cash Flow > net Change In Cash
4567
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
122.89344483767614
Annuals > 0 > ratios > ROA
-659.1787190856389
Annuals > 0 > ratios > FCF
-912760
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.0584332229011015
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2009-12-31
Annuals > 1 > income Statement > revenue
734495
Annuals > 1 > income Statement > cost Of Revenue
427297
Annuals > 1 > income Statement > gross Profit
307198
Annuals > 1 > income Statement > operating Expenses
2521600
Annuals > 1 > income Statement > operating Income
-1787105
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-2439851
Annuals > 1 > income Statement > net Income
-2439851
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-243.31071007971462
Annuals > 1 > income Statement > total Other Income Expense Net
-652746
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11357
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
61963
Annuals > 1 > balance Sheet > inventories
520339
Annuals > 1 > balance Sheet > total Current Assets
667775
Annuals > 1 > balance Sheet > property Plant Equipment
4517
Annuals > 1 > balance Sheet > total Assets
3271870
Annuals > 1 > balance Sheet > payables
499071
Annuals > 1 > balance Sheet > short Term Debt
2014125.09
Annuals > 1 > balance Sheet > long Term Debt
737020.82
Annuals > 1 > balance Sheet > total Liabilities
4331190
Annuals > 1 > balance Sheet > equity
-1059320
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2439851
Annuals > 1 > cash Flow > depreciation
52694
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-948388
Annuals > 1 > cash Flow > capital Expenditures
4517
Annuals > 1 > cash Flow > cash From Investing
-4517
Annuals > 1 > cash Flow > cash From Financing
956129
Annuals > 1 > cash Flow > net Change In Cash
3224
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
230.3223766189631
Annuals > 1 > ratios > ROA
-74.57053611543246
Annuals > 1 > ratios > FCF
-952905
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1.297360771686669
Annuals > 1 > health Score
41
Annuals > 2 > quarter
2008-12-31
Annuals > 2 > income Statement > revenue
910577
Annuals > 2 > income Statement > cost Of Revenue
519130
Annuals > 2 > income Statement > gross Profit
391447
Annuals > 2 > income Statement > operating Expenses
5720759
Annuals > 2 > income Statement > operating Income
-4810182
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-6406954
Annuals > 2 > income Statement > net Income
-6406954
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-528.2564791335604
Annuals > 2 > income Statement > total Other Income Expense Net
-1596772
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
8133
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
197470
Annuals > 2 > balance Sheet > inventories
784278
Annuals > 2 > balance Sheet > total Current Assets
1350696
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
1350696
Annuals > 2 > balance Sheet > payables
714966
Annuals > 2 > balance Sheet > short Term Debt
1855831.03
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
4102959
Annuals > 2 > balance Sheet > equity
-2752263
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6406954
Annuals > 2 > cash Flow > depreciation
1140
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-140386
Annuals > 2 > cash Flow > capital Expenditures
4517
Annuals > 2 > cash Flow > cash From Investing
-4517
Annuals > 2 > cash Flow > cash From Financing
140555
Annuals > 2 > cash Flow > net Change In Cash
169
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
232.78858161447508
Annuals > 2 > ratios > ROA
-474.3446341737889
Annuals > 2 > ratios > FCF
-144903
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.15913316501514974
Annuals > 2 > health Score
40
Annuals > 3 > quarter
2007-12-31
Annuals > 3 > income Statement > revenue
269970
Annuals > 3 > income Statement > cost Of Revenue
384235
Annuals > 3 > income Statement > gross Profit
-114265
Annuals > 3 > income Statement > operating Expenses
3129568
Annuals > 3 > income Statement > operating Income
-2859598
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-3344505
Annuals > 3 > income Statement > net Income
-3344505
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-1059.2280623773013
Annuals > 3 > income Statement > total Other Income Expense Net
-484907
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
7964
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
147680
Annuals > 3 > balance Sheet > inventories
891296
Annuals > 3 > balance Sheet > total Current Assets
1179713
Annuals > 3 > balance Sheet > property Plant Equipment
1140
Annuals > 3 > balance Sheet > total Assets
1180853
Annuals > 3 > balance Sheet > payables
501159
Annuals > 3 > balance Sheet > short Term Debt
1801533.81
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
2877023
Annuals > 3 > balance Sheet > equity
-1696170
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3344505
Annuals > 3 > cash Flow > depreciation
21632
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-1676622
Annuals > 3 > cash Flow > capital Expenditures
4517
Annuals > 3 > cash Flow > cash From Investing
-4517
Annuals > 3 > cash Flow > cash From Financing
1663461
Annuals > 3 > cash Flow > net Change In Cash
-13161
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
197.17982277719804
Annuals > 3 > ratios > ROA
-283.22788695968086
Annuals > 3 > ratios > FCF
-1681139
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-6.2271326443678925
Annuals > 3 > health Score
40
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
9.867502255019973
Profitability > metrics > ROA
-123.53654985716871
Profitability > metrics > Net Margin
-1.78532630946857
Profitability > final Score
20
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.1739558231257348
Risk > final Score
25
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.468896445961763
Liquidity > metrics > Quick Ratio
0.25487778058216026
Liquidity > final Score
23
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
12
Prev Risks > 1
27
Prev Risks > 2
22
Prev Liquidities > 0
31
Prev Liquidities > 1
14
Prev Liquidities > 2
13
Updated At
2026-01-20T21:28:31.768Z
Earnings History > 0 > period
2011-09-30
Earnings History > 0 > report Date
2011-11-10
Earnings History > 0 > date
2011-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.25
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.25
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2011-06-30
Earnings History > 1 > report Date
2011-09-30
Earnings History > 1 > date
2011-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0489
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0489
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2011-03-31
Earnings History > 2 > report Date
2011-05-04
Earnings History > 2 > date
2011-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.13
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.13
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2010-12-31
Earnings History > 3 > report Date
2011-02-03
Earnings History > 3 > date
2010-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.3
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.3
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2010-09-30
Earnings History > 4 > report Date
2010-11-04
Earnings History > 4 > date
2010-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.26
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.26
Earnings History > 4 > surprise Percent
-
American Scientific Resources, Incorporated develops, manufactures, assembles, markets, and distributes medical products and devices for children and adults. It offers Thermofocus 5-in-1, a non-contact clinical thermometer; VeraTemp and VeraTemp+ non-contact thermometers; Scald Safe Water temperature disc, a warning disc that helps to ensure that a baby's bath water is at an appropriate temperature; and WhistleWatch, a flow monitoring device that allows parents to monitor their child's respiratory problems. The company also provides Kidz-Med portable ultrasonic nebulizer, which is used to treat asthma, bronchitis, allergies, and sinusitis; Kidz-Med Medicine Dispenser that consists of an orthodontic nipple attached to a medication chamber; and Kidz-Med Mommy Recorder, a voice-recording device, which allows a mother to record a message designed to calm baby when he or she is upset. In addition, it offers Bip DVDs, a video series to help children understand life events; Mebby product line that includes breast pumps, bisphenol A free baby bottles, digital scales, humidifiers, pacifiers, & sterilizers; and Wee Target, a toilet training device for young boys. Further, the company provides Disintegrator, a home needle and lancet destruction device, which enables patients who give themselves injections, including those suffering from multiple sclerosis or diabetes to properly and safely dispose of needles at home. American Scientific Resources distributes its products primarily through retail drug and grocery chains, and medical suppliers, as well as through its Web site and other on-line sites. The company is based in Weston, Florida. On February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against American Scientific Resources, Incorporated in the US Bankruptcy Court for the Southern District of Florida. On March 28, 2012, the involuntary petition was approved by the Court. American Scientific Resources, Inc. is in liquidation.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2011-09-30)
Health Score
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of American Scientf
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2011-09-30
EPS Actual
-0.25
EPS Estimate
0
EPS Difference
-0.25
Surprise Percent
0%
(Last Updated 2011-09-30)
(Last Updated 2011-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2011-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2011-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.